Cargando…

Drug Choices and Advancements for Managing Depression in Parkinson's Disease

Depression is a frequent non-motor symptom of Parkinson’s disease (PD), and may even precede the onset of motor symptoms of parkinsonism. Beyond its negative influence on mood, depression in PD is frequently associated with other neuropsychiatric symptoms and with late-stage complications such as de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Assogna, Francesca, Pellicano, Clelia, Savini, Cinzia, Macchiusi, Lucia, Pellicano, Gaia R., Alborghetti, Marika, Caltagirone, Carlo, Spalletta, Gianfranco, Pontieri, Francesco E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327944/ https://www.ncbi.nlm.nih.gov/pubmed/31622207 http://dx.doi.org/10.2174/1570159X17666191016094857

Ejemplares similares

Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism
por: Assogna, Francesca, et al.
Publicado: (2019)

Psychiatric profile of motor subtypes of de novo drug‐naïve Parkinson's disease patients
por: Assogna, Francesca, et al.
Publicado: (2018)

Immune System and Neuroinflammation in Idiopathic Parkinson’s Disease: Association Analysis of Genetic Variants and miRNAs Interactions
por: Strafella, Claudia, et al.
Publicado: (2021)

Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease
por: Assogna, Francesca, et al.
Publicado: (2021)

Foot Pressure Wearable Sensors for Freezing of Gait Detection in Parkinson’s Disease
por: Marcante, Andrea, et al.
Publicado: (2020)

Cerebellar GABA Levels and Cognitive Interference in Parkinson’s disease and Healthy Comparators
por: Piras, Federica, et al.
Publicado: (2020)

Depressive symptoms in Parkinson’s disease and in non-neurological medical illnesses
por: Assogna, Francesca, et al.
Publicado: (2013)

Narrative discourse production in Parkinson’s disease: Decoupling the role of cognitive-linguistic and motor speech changes
por: D’Ascanio, Sara, et al.
Publicado: (2023)

Feasibility and Utility of mHealth for the Remote Monitoring of Parkinson Disease: Ancillary Study of the PD_manager Randomized Controlled Trial
por: Gatsios, Dimitris, et al.
Publicado: (2020)

Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson’s Disease and Is Associated with Motor Symptom Severity
por: Ciaramella, Antonio, et al.
Publicado: (2013)

Prodromal non-motor symptoms of Parkinson’s disease
por: Pellicano, Clelia, et al.
Publicado: (2007)

The impact of extended release dopamine agonists on prescribing patterns for therapy of early Parkinson’s disease: an observational study
por: Pellicano, Clelia, et al.
Publicado: (2013)

The Dopaminergic System in Peripheral Blood Lymphocytes: From Physiology to Pharmacology and Potential Applications to Neuropsychiatric Disorders
por: Buttarelli, Francesca R, et al.
Publicado: (2011)

Action Observation With Dual Task for Improving Cognitive Abilities in Parkinson’s Disease: A Pilot Study
por: Caligiore, Daniele, et al.
Publicado: (2019)

Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders
por: Zampatti, Stefania, et al.
Publicado: (2021)

Gender specific decrease of a set of circulating N-acylphosphatidyl ethanolamines (NAPEs) in the plasma of Parkinson’s disease patients
por: Hamid, Zeeshan, et al.
Publicado: (2019)

Monoamine-oxidase Type B Inhibitors and Cognitive Functions in Parkinson’s Disease: Beyond the Primary Mechanism of Action
por: Rinaldi, Domiziana, et al.
Publicado: (2023)

Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease
por: Bianchini, Edoardo, et al.
Publicado: (2022)

Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment
por: Bossù, Paola, et al.
Publicado: (2018)

Subclinical Cognitive and Neuropsychiatric Correlates and Hippocampal Volume Features of Brain White Matter Hyperintensity in Healthy People
por: Spalletta, Gianfranco, et al.
Publicado: (2020)

Myeloid dendritic cells are decreased in peripheral blood of Alzheimer’s disease patients in association with disease progression and severity of depressive symptoms
por: Ciaramella, Antonio, et al.
Publicado: (2016)

Age at Onset Influences Progression of Motor and Non-Motor Symptoms during the Early Stage of Parkinson’s Disease: A Monocentric Retrospective Study
por: De Carolis, Lanfranco, et al.
Publicado: (2023)

High serum levels of transforming growth factor β1 are associated with increased cortical thickness in cingulate and right frontal areas in healthy subjects
por: Piras, Fabrizio, et al.
Publicado: (2012)

Hippocampal volume and depressive symptoms are linked to serum IL-18 in schizophrenia
por: Bossù, Paola, et al.
Publicado: (2015)

Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch
por: Bianchini, Edoardo, et al.
Publicado: (2023)

Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases
por: Bossù, Paola, et al.
Publicado: (2015)

Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings
por: Alborghetti, Marika, et al.
Publicado: (2023)

Brain microstructural changes and cognitive correlates in patients with pure obsessive compulsive disorder
por: Spalletta, Gianfranco, et al.
Publicado: (2014)

GABA System in Schizophrenia and Mood Disorders: A Mini Review on Third-Generation Imaging Studies
por: Chiapponi, Chiara, et al.
Publicado: (2016)

Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
por: Alborghetti, Marika, et al.
Publicado: (2019)

Designing a mHealth clinical decision support system for Parkinson’s disease: a theoretically grounded user needs approach
por: Timotijevic, L., et al.
Publicado: (2020)

Polygenic determinants of white matter volume derived from GWAS lack reproducibility in a replicate sample
por: Papiol, S, et al.
Publicado: (2014)

Influence of APOE and RNF219 on Behavioral and Cognitive Features of Female Patients Affected by Mild Cognitive Impairment or Alzheimer’s Disease
por: Mosca, Alessandra, et al.
Publicado: (2018)

Cortical Grey Matter and Subcortical White Matter Brain Microstructural Changes in Schizophrenia Are Localised and Age Independent: A Case-Control Diffusion Tensor Imaging Study
por: Chiapponi, Chiara, et al.
Publicado: (2013)

Time Dysperception Perspective for Acquired Brain Injury
por: Piras, Federica, et al.
Publicado: (2014)

Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study
por: Colombo, Delia, et al.
Publicado: (2018)

Step-Counting Accuracy of a Commercial Smartwatch in Mild-to-Moderate PD Patients and Effect of Spatiotemporal Gait Parameters, Laterality of Symptoms, Pharmacological State, and Clinical Variables
por: Bianchini, Edoardo, et al.
Publicado: (2022)

The Italian Validation of the Beck Cognitive Insight Scale: Underlying Factor Structure in Psychotic Patients and the General Population
por: Orfei, Maria Donata, et al.
Publicado: (2023)

Left hippocampus–amygdala complex macro- and microstructural variation is associated with BDNF plasma levels in healthy elderly individuals
por: Manna, Antonietta, et al.
Publicado: (2015)

Modafinil-Induced Changes in Functional Connectivity in the Cortex and Cerebellum of Healthy Elderly Subjects
por: Punzi, Miriam, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jjei98khl801l8nl981bgms557